Stability analysis of vascular endothelial growth factor in cerebrospinal fluid

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 1947-1954

  Yang, Jun ^a   Dombrowski, Stephen M ^a   Deshpande, Abhishek ^a   Krajcir, Natalie ^a   El Khoury, Serge ^a   Krishnan, Chandra ^a   Luciano, Mark G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cell count; Centrifugation; Preservation; Temperature; Time

Indexed keywords

VASCULOTROPIN;

ARTICLE; CELL AGGREGATION; CELL COMPOSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HUMAN; HUMAN CELL; INCUBATION TIME; PRESERVATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN STABILITY; ROOM TEMPERATURE; SAMPLING; STORAGE; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL SEPARATION; CENTRIFUGATION; CEREBROSPINAL FLUID; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMANS; MALE; MIDDLE AGED; SPECIMEN HANDLING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80055009026     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0517-z     Document Type: Article

References (28)

1. N Ferrara 2010 Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy Nat Med 16 1107 1111 20930754 10.1038/nm1010-1107 1:CAS:528:DC%2BC3cXht1GrtbnE
2. N Ferrara 1999 Molecular and biological properties of vascular endothelial growth factor J Mol Med (JMM) 77 527 543 10.1007/s001099900019 1:CAS:528:DyaK1MXmsFOiurY%3D (Pubitemid 29426311)
3. N Ferrara 1996 Vascular endothelial growth factor Eur J Cancer 32A 2413 2422 9059329 10.1016/S0959-8049(96)00387-5 1:CAS:528:DyaK2sXhsFCnsLY%3D (Pubitemid 27080779)
4. SM Dombrowski A Deshpande C Dingwall, et al. 2008 Chronic hydrocephalus-induced hypoxia: increased expression of VEGFR-2+ and blood vessel density in hippocampus Neuroscience 152 346 359 18262364 10.1016/j. neuroscience.2007.11.049 1:CAS:528:DC%2BD1cXjs1Kqtb0%3D
5. J Yang SM Dombrowski A Deshpande, et al. 2010 VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus J Neurol Sci 296 39 46 20619858 10.1016/j.jns.2010.06.012 1:CAS:528: DC%2BC3cXpsFOlt7k%3D
6. A Deshpande SM Dombrowski A Leichliter, et al. 2009 Dissociation between vascular endothelial growth factor receptor-2 and blood vessel density in the caudate nucleus after chronic hydrocephalus J Cereb Blood Flow Metab 29 1806 1815 19675561 10.1038/jcbfm.2009.98 1:CAS:528:DC%2BD1MXhtlegsb7L
7. C Moreau D Devos V Brunaud-Danel, et al. 2006 Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS J Neurol Neurosurg Psychiatry 77 255 257 16421133 10.1136/jnnp.2005.070904 1:STN:280: DC%2BD28%2FjtlGnsQ%3D%3D (Pubitemid 43220855)
8. WT Hu A Chen-Plotkin SE Arnold, et al. 2010 Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment Acta Neuropathol 119 669 678 20232070 10.1007/s00401-010-0667-0 1:CAS:528:DC%2BC3cXlslWgtLg%3D
9. A Tarnaris AK Toma MD Chapman, et al. 2009 The longitudinal profile of CSF markers during external lumbar drainage J Neurol Neurosurg Psychiatry 80 1130 1133 19535354 10.1136/jnnp.2008.171686 1:STN:280:DC%2BD1MnjtVWksQ%3D%3D
10. E Hormbrey P Gillespie K Turner, et al. 2002 A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastas 19 651 663 10.1023/A: 1021379811308 1:CAS:528:DC%2BD38Xpt1Kqur4%3D (Pubitemid 36092260)
11. JJ Provencio P Kivisakk BH Tucky, et al. 2005 Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients J Neuroimmunol 163 179 184 15885320 10.1016/j.jneuroim.2005.03. 003 1:CAS:528:DC%2BD2MXktVGlur0%3D (Pubitemid 40692961)
12. RE Banks MA Forbes SE Kinsey, et al. 1998 Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology Br J Cancer 77 956 964 9528841 10.1038/bjc.1998.158 1:CAS:528:DyaK1cXitlyrtrY%3D (Pubitemid 28101786)
13. JP Maloney CC Silliman DR Ambruso, et al. 1998 In vitro release of vascular endothelial growth factor during platelet aggregation Am J Physiol 275 H1054 H1061 9724313 1:CAS:528:DyaK1cXmtFWjtL4%3D
14. E Gunsilius A Petzer G Stockhammer, et al. 2000 Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood Oncology 58 169 174 10705245 10.1159/000012095 1:CAS:528:DC%2BD3cXis1Siu7k%3D (Pubitemid 30113869)
15. R Mohle D Green MA Moore, et al. 1997 Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Proc Natl Acad Sci USA 94 663 668 9012841 10.1073/pnas.94.2.663 1:CAS:528:DyaK2sXnvVejsQ%3D%3D (Pubitemid 27053690)
16. U Wartiovaara P Salven H Mikkola, et al. 1998 Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation Thromb Haemost 80 171 175 9684805 1:CAS:528:DyaK1cXkslWmsLg%3D (Pubitemid 28353517)
17. KJ O'byrne N Dobbs D Propper, et al. 1999 Vascular endothelial growth factor platelet counts, and prognosis in renal cancer Lancet 353 1494 1495 10232320 10.1016/S0140-6736(99)00471-7 (Pubitemid 29204372)
18. AL Harris 1998 Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy Recent Results Cancer Res 152 341 352 9928571 1:STN:280:DyaK1M7islGgsA%3D%3D
19. P Salven L Teerenhovi H Joensuu 1997 A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma Blood 90 3167 3172 9376599 1:CAS:528:DyaK2sXms1Gjtrs%3D (Pubitemid 27444212)
20. MR Freeman FX Schneck ML Gagnon, et al. 1995 Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis Cancer Res 55 4140 4145 7545086 1:CAS:528:DyaK2MXotV2mt7k%3D
21. B Berse LF Brown L Van De Water, et al. 1992 Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors Mol Biol Cell 3 211 220 1550962 1:CAS:528:DyaK38XitFajsL4%3D (Pubitemid 23084552)
22. I Aursnes V Vikholm 1984 On a possible interaction between ADP and mechanical stimulation in platelet activation Thromb Haemost 51 54 56 6719389 1:CAS:528:DyaL2cXhsFegsLw%3D (Pubitemid 14159200)
23. NJ Webb MJ Bottomley CJ Watson, et al. 1998 Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease Clin Sci (Lond) 94 395 404 1:CAS:528:DyaK1cXislansrs%3D (Pubitemid 28176624)
24. TJ Reid VF Larussa G Esteban, et al. 1999 Cooling and freezing damage platelet membrane integrity Cryobiology 38 209 224 10328911 10.1006/cryo.1999. 2164 1:CAS:528:DyaK1MXjtVSjsr4%3D (Pubitemid 29399449)
25. C Sanz A Pereira AI Faundez, et al. 1997 Prolonged holding of whole blood at 22 degrees C does not increase activation in platelet concentrates Vox Sang 72 225 228 9228712 10.1046/j.1423-0410.1997.7240225.x 1:STN:280: DyaK2sznt1Crtw%3D%3D (Pubitemid 27277715)
26. J Jacobsen T Rasmuson K Grankvist, et al. 2000 Vascular endothelial growth factor as prognostic factor in renal cell carcinoma J Urol 163 343 347 10604387 10.1016/S0022-5347(05)68049-4 1:STN:280:DC%2BD3c%2FmslyktA%3D%3D
27. W Wynendaele R Derua MF Hoylaerts, et al. 1999 Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 10 965 971 10509160 10.1023/A:1008377921886 1:STN:280: DyaK1MvjvVGktA%3D%3D (Pubitemid 29424578)
28. P Salven T Ruotsalainen K Mattson, et al. 1998 High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer Int J Cancer 79 144 146 9583728 10.1002/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T 1:STN:280:DyaK1c3ktlSrtA%3D%3D (Pubitemid 28201685)